[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363418-105":59,"doc-detail-363418-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","aberrant-glycosylation-in-hematologic-malignancies-mechanisms-immune-evasion-and-therapeutic-targeting","Aberrant glycosylation in hematologic malignancies - mechanisms, immune evasion, and therapeutic targeting","","Hematologic malignancies are highly heterogeneous blood and lymphatic cancers with rapid progression and poor prognosis. Glycosylation, a common post-translational modification, is shown to regulate disease development through abnormal patterns that affect tumor signaling, the tumor microenvironment, cellular recognition, and immune evasion. This review synthesizes advances linking dysregulated glycosylation to leukemia, lymphoma, myeloma, and related biology, and evaluates glycosylation products as biomarkers for diagnosis and prognosis.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/aberrant-glycosylation-in-hematologic-malignancies-mechanisms-immune-evasion-and-therapeutic-targeting/363418/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/aberrant-glycosylation-in-hematologic-malignancies-mechanisms-immune-evasion-and-therapeutic-targeting/363418.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What roles does aberrant glycosylation play in hematologic malignancies?","Question",{"text":113,"@type":114},"Aberrant glycosylation influences tumor cell signaling, the tumor microenvironment, cellular recognition, and immune evasion, thereby promoting progression and therapeutic resistance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which main types of glycosylation are discussed?",{"text":118,"@type":114},"The review covers N-glycosylation, O-glycosylation (including O-GalNAc and O-GlcNAc), C-glycosylation, glycosylphosphatidylinositol-anchored glycosylation, and additional modifications such as sialylation, fucosylation, and sulfation.",{"name":120,"@type":111,"acceptedAnswer":121},"How does dysregulated glycosylation connect to immune evasion?",{"text":122,"@type":114},"By altering glycan structure and protein modifications, aberrant glycosylation can change how cells are recognized and can support mechanisms that evade immune responses.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},363418,1790194456,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","Blood Cancer [Journal](Journal www.nature.com/bcj)[ www.nature.com/bcj](Journal www.nature.com/bcj)  \nREVIEW ARTICLE OPEN   \nAberrant glycosylation in hematologic malignancies: mechanisms, immune evasion, and therapeutic targeting  \nXiao Lu1,2, Zhouying Song 1,2, Chunhui Wang1, Bing Pan1, Ziqi Xu1, Zilong Wang 1, Hequn Wang1, Xiaobo Wang 1 ✉ and Bo Tang 1 ✉  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | Hematologic malignancies are a group of malignant diseases originating from hematopoietic stem cells or the lymphatic system, mainly including leukemia, lymphoma, myeloma and so on. These diseases are characterized by their high heterogeneity, rapid disease progression and poor prognosis. Glycosylation is one of the most common post-translational modiﬁcations. In recent years, it has been found that abnormal glycosylation plays an important role in the genesis, development and treatment of hematologic malignancies. Aberrant glycosylation has been demonstrated to exert a signiﬁcant inﬂuence on the progression of disease, impacting various biological processes including tumor cell signaling, the tumor microenvironment, cellular recognition, and immune evasion. This review synthesizes recent advances in how dysregulated glycosylation drives the biology of leukemia, lymphoma, myeloma, and other types of malignancies. Additionally, it discusses the potential value of glycosylation products that |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| can be used as biomarkers for disease diagnosis and prognosis. |  |  |\n|  | Blood Cancer Journal (2026)16:75; [https://doi.org/10.1038/s41408-026-01493-z](https://doi.org/10.1038/s41408-026-01493-z) |  |\n|  |  |  |\n\nINTRODUCTION  \nGlycosylation, a ubiquitous post-translational modiﬁcation, plays a pivotal role in regulating protein stability, cellular communication, and immune responses [1] . This enzymatic process involves the glycans transferred to speciﬁc amino acid residues in proteins by glycosyltransferases, which shapes their functional diversity [2] . Most glycans are assembled and initially matured in the lumen of the endoplasmic reticulum, and some of them require further trimming through the Golgi [3] . Mature glycoproteins are then distributed to different locations such as the cell membrane or secreted outside the cell.  \nGlycosylation encompasses a variety of types, each with distinct roles and mechanisms (Fig. 1) [4] . N-glycosylation, the predominant form, involves the transfer of an oligosaccharide chain containing N-acetylglucosamine (GlcNAc) to the asparagine residue of proteins, a process catalyzed by glycosyltransferases [5] . This modiﬁcation is essential for protein folding and quality control, particularly within the endoplasmic reticulum, where it facilitates the proper folding of nascent glycoproteins through interactions with the glycoprotein chaperone system [6] . Oglycosylation, which involves the attachment of sugar moieties to serine or threonine residues, occurs predominantly in the cytoplasm and nucleus [7] . This modiﬁcation plays a crucial role in regulating protein stability and function, particularly in processes such as cell adhesion and immune evasion [4] . O-glycosylation includes two primary types: O-GalNAc and O-linked β-D-N-acetylglucosamine (O-GlcNAc) [8] . The initiation of O-GalNAc glycosylation is catalyzed by N-acetylgalactosamine (GalNAc) transferase, and it is expressed in a variety of tumor types and plays a role in cell-cell interaction, and cell-matrix interactions [9] . On the other hand, O-GlcNAc glycosylation is regulated by  \nO-GlcNAc transferase and O-GlcNAcase, inﬂuencing protein modiﬁcation and being implicated in the progression and invasiveness of tumors [10] . C-glycosylation, a relatively rare form of glycosylation, involves the covalent attachment of mannose to the tryptophan residue via a C-C bond. This modiﬁcation is typically observed in speciﬁc protein classes, such a","cbCaipq9SO7YfzXM","https://ap.wps.com/l/cbCaipq9SO7YfzXM","pdf",1700386,12,"English","# Introduction\n## Types and mechanisms of glycosylation\n## Glycosylation as a driver in hematologic malignancies\n# Aberrant glycosylation impacts multiple disease dimensions\n# Therapeutic targeting and biomarker potential","[{\"question\":\"What roles does aberrant glycosylation play in hematologic malignancies?\",\"answer\":\"Aberrant glycosylation influences tumor cell signaling, the tumor microenvironment, cellular recognition, and immune evasion, thereby promoting progression and therapeutic resistance.\"},{\"question\":\"Which main types of glycosylation are discussed?\",\"answer\":\"The review covers N-glycosylation, O-glycosylation (including O-GalNAc and O-GlcNAc), C-glycosylation, glycosylphosphatidylinositol-anchored glycosylation, and additional modifications such as sialylation, fucosylation, and sulfation.\"},{\"question\":\"How does dysregulated glycosylation connect to immune evasion?\",\"answer\":\"By altering glycan structure and protein modifications, aberrant glycosylation can change how cells are recognized and can support mechanisms that evade immune responses.\"}]","Aberrant glycosylation in hematologic malignancies - mechanisms, immune evasion, and therapeutic targeting | PDF",1790151139,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/597da417df1a9e2bb56071d67441a7f8.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c6152018b438de2a82822f155b6736b.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d95a0d8198accea04efde0ead99215e5.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc2c1fe29793a0dce754ca0d3b4ea747.webp",980,1301]